InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

- Current share price for ATX : $0.150

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$77 Change in substantial holding 27 Nov 2024 4:22PM $0.087 $0.150 risen by 72.41%
$77 App 4D and Financial Report Half Year ended 30 Sep 2024 27 Nov 2024 2:51PM $0.086 $0.150 risen by 74.42%
$77 Successful Completion of Retail Entitlement Offer 27 Nov 2024 8:45AM $0.092 $0.150 risen by 63.04%
$77 Security Class Suspension from Quotation 25 Nov 2024 9:13AM $0.088 $0.150 risen by 70.45%
$77 Notice of Extraordinary General Meeting/Proxy Form 18 Nov 2024 4:30PM $0.094 $0.150 risen by 59.57%
$77 Amplia Enters into Preclinical Collaboration 14 Nov 2024 9:16AM $0.100 $0.150 risen by 50%
$77 Change in substantial holding 8 Nov 2024 5:03PM $0.093 $0.150 risen by 61.29%
$77 Section 708A(5)(e) Notice - Allotment of 67,723,015 Shares 7 Nov 2024 2:28PM $0.094 $0.150 risen by 59.57%
$77 Substantial Holder Notice - Blueflag Holding Pty Ltd 6 Nov 2024 4:18PM $0.096 $0.150 risen by 56.25%
$77 Application for quotation of securities - ATX 6 Nov 2024 11:33AM $0.103 $0.150 risen by 46.34%
$77 Proposed issue of securities - ATX 5 Nov 2024 9:33AM $0.105 $0.150 risen by 42.86%
$77 Update - Proposed issue of securities - ATX 1 Nov 2024 10:39AM $0.135 $0.150 risen by 11.11%
$77 Replacement Prospectus 1 Nov 2024 10:38AM $0.135 $0.150 risen by 11.11%
$77 Amplia Successfully Completes Institutional Offer 1 Nov 2024 10:35AM $0.135 $0.150 risen by 11.11%
$77 Proposed issue of securities - ATX 31 Oct 2024 8:23AM $0.135 $0.150 risen by 11.11%
$77 Proposed issue of securities - ATX 30 Oct 2024 11:46AM $0.135 $0.150 risen by 11.11%
$77 Proposed issue of securities - ATX 30 Oct 2024 11:31AM $0.135 $0.150 risen by 11.11%
$77 Capital Raise Prospectus 30 Oct 2024 11:16AM $0.135 $0.150 risen by 11.11%
$77 Capital Raise Presentation 30 Oct 2024 11:15AM $0.135 $0.150 risen by 11.11%
$77 Amplia to Raise up to $13m for ACCENT and US Trials 30 Oct 2024 11:12AM $0.135 $0.150 risen by 11.11%
$77 Interim Data From Accent Pancreatic Cancer Trial 30 Oct 2024 10:40AM $0.135 $0.150 risen by 11.11%
$77 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2024 10:19AM $0.135 $0.150 risen by 11.11%
$77 Trading Halt 30 Oct 2024 9:06AM $0.135 $0.150 risen by 11.11%
$77 Recruitment Restarts in ACCENT Pancreatic Cancer Trial 16 Oct 2024 10:01AM $0.150 $0.150 fallen by 0%
$77 Sixth Confirmed Response in Pancreatic Cancer Trial 23 Sep 2024 8:35AM $0.135 $0.150 risen by 11.11%

126 - 150 of 538 results

Page 6 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.